Phantomics announced the successful completion of its 1st User Summit – 2024 CMR Symposium, held on October 11. The event was organized for cardiologists and radiologists to engage with the company’s flagship MRI-based cardiac disease diagnosis AI solution, Myomics, which is actively utilized in diagnostic and clinical practices.
The summit introduced new features of Myomics, focusing on the latest AutoLGE update. AutoLGE, an automated late gadolinium enhancement quantification technology, reduces variability among users in analyzing LGE (a critical imaging technique for diagnosing myocardial diseases). This innovation enhances diagnostic accuracy and simplifies workflows, enabling medical professionals to provide faster and improved cardiac care.
Additionally, Phantomics unveiled the MyoReport feature, which extends beyond auto-generated text-based reports by suggesting potential suspected diseases, offering deeper clinical insights.
Phantomics emphasized that these new features are expected to streamline diagnostic procedures further and offer actionable insights into patient conditions, enhancing overall healthcare delivery.
Pan Ki Kim, Co-CEO of Phantomics, commented, “This summit was a meaningful opportunity to gain valuable feedback on real-world AI needs from healthcare professionals. We will continue to use user summits to introduce new functionalities, integrate diverse user requirements into our technology, and support medical professionals and patients with better outcomes. Ultimately, we aim to contribute to overcoming cardiovascular diseases.”
Phantomics plans to host regular user summits to share updates on its developments and collaborate with medical professionals to refine its solutions. The company remains committed to leveraging AI to transform cardiac care and support the fight against cardiovascular diseases worldwide.
Read Article
Phantomics announced the successful completion of its 1st User Summit – 2024 CMR Symposium, held on October 11. The event was organized for cardiologists and radiologists to engage with the company’s flagship MRI-based cardiac disease diagnosis AI solution, Myomics, which is actively utilized in diagnostic and clinical practices.
The summit introduced new features of Myomics, focusing on the latest AutoLGE update. AutoLGE, an automated late gadolinium enhancement quantification technology, reduces variability among users in analyzing LGE (a critical imaging technique for diagnosing myocardial diseases). This innovation enhances diagnostic accuracy and simplifies workflows, enabling medical professionals to provide faster and improved cardiac care.
Additionally, Phantomics unveiled the MyoReport feature, which extends beyond auto-generated text-based reports by suggesting potential suspected diseases, offering deeper clinical insights.
Phantomics emphasized that these new features are expected to streamline diagnostic procedures further and offer actionable insights into patient conditions, enhancing overall healthcare delivery.
Pan Ki Kim, Co-CEO of Phantomics, commented, “This summit was a meaningful opportunity to gain valuable feedback on real-world AI needs from healthcare professionals. We will continue to use user summits to introduce new functionalities, integrate diverse user requirements into our technology, and support medical professionals and patients with better outcomes. Ultimately, we aim to contribute to overcoming cardiovascular diseases.”
Phantomics plans to host regular user summits to share updates on its developments and collaborate with medical professionals to refine its solutions. The company remains committed to leveraging AI to transform cardiac care and support the fight against cardiovascular diseases worldwide.
Read Article